Improved human islet preparations using glucocorticoid and exendin-4.

about

Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review.

P2860

Q38692970-C8249ADE-CF7D-4B03-B250-C9732E17473C

P2860

Improved human islet preparations using glucocorticoid and exendin-4.

Item

http://www.wikidata.org/entity/Q42957118

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Improved human islet preparations using glucocorticoid and exendin-4.

@en

Improved human islet preparations using glucocorticoid and exendin-4.

@nl

type

Item

label

Improved human islet preparations using glucocorticoid and exendin-4.

@en

Improved human islet preparations using glucocorticoid and exendin-4.

@nl

prefLabel

Improved human islet preparations using glucocorticoid and exendin-4.

@en

Improved human islet preparations using glucocorticoid and exendin-4.

@nl

P1476

Improved human islet preparations using glucocorticoid and exendin-4.

@en

P2093

Atsushi Miki

http://www.w3.org/2001/XMLSchema#string

Atsuyoshi Mita

http://www.w3.org/2001/XMLSchema#string

Luca Inverardi

http://www.w3.org/2001/XMLSchema#string

Rodolfo Alejandro

http://www.w3.org/2001/XMLSchema#string

Ryosuke Misawa

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yasunaru Sakuma

http://www.w3.org/2001/XMLSchema#string

P2860

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

Biology of incretins: GLP-1 and GIP

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.

Characterization of pancreatic ductal cells in human islet preparations.

Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha

Clinical islet transplantation: advances and immunological challenges.

Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.

Immunosuppressive agents: effects on glucose and lipid metabolism.

Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

P304

1317-1322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0000000000000184

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Camillo Ricordi

Hirohito Ichii

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25036907

http://www.w3.org/2001/XMLSchema#string

P932

4206594

http://www.w3.org/2001/XMLSchema#string

Improved human islet preparations using glucocorticoid and exendin-4.

about

P2860

P2860

Improved human islet preparations using glucocorticoid and exendin-4.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932